Global Market Study on Facial Rejuvenation: Early onset of Ageing and Rising Adoption of minimally Invasive Procedures to Drive the Market


  • Published On : Jan-2016 |
  • Pages : 185 Pages |
  • Format :

This Persistence Market Research (PMR) report examines the ‘Global Facial rejuvenation Market for the period 2015-2021. The primary objective of the report is to offer updates and information related to market opportunities in the Global Facial rejuvenation Market.

This Persistence Market Research (PMR) report examines the facial rejuvenation market for the period 2015-2021. The primary objective of the report is to offer insights into developments in the facial rejuvenation market that are significantly transforming global businesses and enterprises.

Facial rejuvenation is a non-invasive or minimally invasive cosmetic treatment (often performed over multiple sittings), which aims to restore skin elasticity and help maintain a youthful appearance in the face and neck region. Facial rejuvenation processes are performed over beauty clinics, hospitals and full-service spas. The process is supported by the guidance of a dermatologist and plastic surgeons.

Early onset of ageing from the thirties - a by-product of lifestyle changes, occurring due to rising personal disposable income levels, is expected to bolster the growth of the facial rejuvenation market over the next five years. Also, increasing popularity and rising adoption rates for minimally invasive and non-invasive cosmetic procedures in both developed and developing economies is expected to drive the growth of facial rejuvenation market during the forecast period. Companies are focusing on affluent regions and sections where there is rising cases of early ageing due to changes in lifestyle such as North America, Europe and Latin America.

The facial rejuvenation market segmented as follows:

  • Facial Rejuvenation Market, by product type
  • Facial Rejuvenation Market, by end use
  • Facial Rejuvenation Market, by region

This report covers the global Facial Rejuvenation Market market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global Facial Rejuvenation Market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

The facial rejuvenation market report begins with an overview of the facial rejuvenation process and why are the patients worldwide adopting the process. This section also underlines factors influencing the growth of the facial rejuvenation market along with detailing of the key trends, drivers, restraints, opportunity and regulations. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in the report to better equip clients with information and hidden insights. At the end of the report, PMR has provided the key strategic recommendation for both existing and new players in the market to emerge sustainably profitable.

The global facial rejuvenation market is segmented based on product type into topical products, botulinum type-A injections, dermal fillers, chemical peels, micro-abrasion equipment and other equipment-based treatments. Based on end users, the market has been segmented into hospitals and dermatology clinics. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index and BPS analysis. In terms of products, botulinum type-A injections are expected to emerge as the product of choice both among physicians and patients worldwide. Dermal fillers would also gain popularity over the forecast period.

The next section of the report highlights the growth trends of the facial rejuvenation market by regions. It provides a market outlook for 2015-2021 and sets the forecast within the context of the facial rejuvenation market. The study discusses key regional trends contributing to the growth of the facial rejuvenation market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia-Pacific and MEA. North America region is expected to emerge dominant and most attractive over the forecast period.

The above sections - by product type, by an end user and by region – evaluate the present scenario and growth prospects of the facial rejuvenation market for the period 2015 - 2021. We have considered 2014 as the base year and provided data for the forecast period.

In the final section of the report, facial rejuvenation ‘Strategic Recommendation’ is included to provide report companies with measures to strengthen footprint in the facial rejuvenation market and differentiate themselves.

Facial rejuvenation is a combination of cosmetic procedures that are used to restore the youthful appearance to the human face. Facial rejuvenation can be achieved through either surgical and/or non-surgical methods. The global market for facial rejuvenation has been segmented based on product type, end users, and five global regions.    

Growth in the facial rejuvenation market is mainly driven by healthy economic growth witnessed in most countries, leading to rising in disposable income levels and lifestyle changes. These often lead to early onset of ageing, thus increasing demand for less painful rejuvenation treatment procedures and quicker results to remain youthful. However, lack of properly trained professionals and limited documented evidence of clinical effectiveness, are factors expected to restrain the growth of the market.

International regulatory harmonization, spanning regions, is set to define the basis for establishing product efficacies, reducing complexity. 

In terms of value, the global facial rejuvenation market is estimated to expand from a value of US$ 18 Bn in 2014 to a value of US$ 26.5 Bn by 2021 end at a CAGR of 4.9% during the forecast period.

Based on product type, the market has been segmented into topical products, botulinum, dermal fillers, chemical peels, microabrasion equipment and laser surfacing treatments. In terms of value, the botulinum product type is estimated to account for ~37% share of the global market by 2021 end, remaining dominant and the most attractive segment.

facial-rejuvenation-market

On the basis of distribution channels, the market has been segmented into hospitals and dermatology clinics. The latter category is the most preferred medium of drug distribution and treatment advising.

The global facial rejuvenation market has been segmented into five major regions, namely North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. In terms of value, North America is estimated to dominate the market, accounting for over a third of the overall market by 2015 end. Latin America and Asia Pacific are estimated to be the fastest-growing emerging markets. Currently, botulinum products are a major revenue contributor in most regions. Among dermal fillers, the hyaluronic acid based fillers used for volume restoration are more preferred over other types. Growing popularity of combination treatments and their rising adoption among customers is expected to boost revenue growth of the facial rejuvenation market in the coming years.

Some of the key players identified in the global facial rejuvenation drug market report include Merz GmbH & Co. KGaA, LUMENIS, Revance Therapeutics, Inc., Biopolymer GmbH &Co KG, Speciality European Pharma, Mentor Worldwide LLC, Anika Therapeutics, Inc., Contura International A/S, Cynosure, Inc., Fibrocell, Inc., and Gal derma S/A. The report is enriched through identification of company-specific strategies related to drug development, market consolidation initiatives, and analyses of the various market player’s specific strengths, weaknesses, opportunities, and threats.

Key competitors covered in terms of manufacturers include:

  • Merz Pharmaceuticals.
  • Lumenis.
  • Revance Therapeutics, Inc.
  • Biopolymer GmbH &Co KG.
  • Speciality European Pharma.
  • Mentor Worldwide LLC.
  • Alma Lasers.
  • Anika Therapeutics, Inc.
  • Contura International A/S.
  • Cynosure, Inc.
  • Fibrocell, Inc.
  • Gal derma S/A.
  • Other
Back To Top